Survey research, focus groups, and interviews
PHE employs a range of methods for eliciting stakeholder preferences. Interviews and focus groups can be used to conduct qualitative and exploratory research when the line of questioning may evolve as input is collected. More formal survey research methods enable drawing qualitative and quantitative conclusions from larger and more representative populations. PHE has access to a number of existing populations for survey research and can assemble custom populations as needed.
A number of survey methods can be used to quantify the value that stakeholders place on treatments and their attributes. A discrete choice experiment (DCE), for example, is a survey tool that allows us to quantify the relative preference for ‘attributes’ of treatments or health states that, in turn, can be modeled to provide estimates of relative value in dollar terms.
PHE determines which approach or technique is best suited for each situation, depending on the level of evidence required, the intended messaging, the target audience for the results, and the need for publication and external dissemination of the results.
- Cope S, et al. Expert elicitation of long-term survival for pediatric acute lymphoblastic leukemia patients receiving CTL019 in Eliana Phase II study. Blood. 2017.
- Lakdawalla DN, et al. How cancer patients value hope and the implications for cost-effectiveness assessments of high-cost cancer therapies. Health Aff (Millwood). 2012.
- Romley JA, et al. Survey results show that adults are willing to pay higher insurance premiums for generous coverage of specialty drugs. Health Aff (Millwood). 2012.
- Sawicki GS, et al. Patient preference for treatment administration in cystic fibrosis. Am J Pharm Benefits. 2015.
- Seabury SA, et al. Patients value metastatic cancer therapy more highly than is typically shown through traditional estimates. Health Aff (Millwood). 2012.
- Shafrin J, et al. Access to credible information on schizophrenia patients’ medication adherence by prescribers can change their treatment strategies: evidence from an online survey of providers. Patient Prefer Adherence. 2017.
- Shafrin J, et al. Patient versus physician valuation of durable survival gains: implications for value framework assessments. Value Health. 2017.
- Shafrin J, et al. Physician and patient preferences for nonvalvular atrial fibrillation therapies. Value Health. 2016.